Patent ID: 7064139
Filing Date: 2006-06-20
Classification: A61K,A61P

Abstract:
1. A method of treating an infection by HCMV or HHV in an afflicted host which comprises administering to the host a therapeutically effective amount of a compound represented by the following formula: or a pharmaceutically acceptable acid-addition or base-addition salt thereof; wherein: component A is a functional group of the following formula:  wherein Z is H, Cl, cyano, alkyl having from 1 to 15 carbon atoms, alkoxyalkyl having 2 or 3 carbon atoms; Y is H or a double bond to a carbon which is attached to R; and R is phenyl, biphenyl, benzyl, naphthyl, anthranyl, pyridyl, thienyl, quinolyl, isoquinolyl or phenyl substituted with 1 to 5 substituents which may be the same or different, the substituents being selected from the group consisting of lower alkyl having from 1 to 5 carbon atoms, halogen, nitro, methoxy, ethoxy, benzyloxy, methylenedioxy, 2,2-dichlorocyclopropyl, trifluoromethyl, methylsulfonyl, cyano and phenoxy; component L is sulfonyl, sulfinyl or thio; and, component B is a functional group of the following formula:  wherein n is 1, R